1 of 1
HOUSE DOCKET, NO. 2249 FILED ON: 1/15/2025
HOUSE . . . . . . . . . . . . . . . No. 1205
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Bradley H. Jones, Jr.
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act establishing a commission to study the promotion of preferred pharmacy networks.
_______________
PETITION OF:
NAME:DISTRICT/ADDRESS :DATE ADDED:Bradley H. Jones, Jr.20th Middlesex1/15/2025Paul K. Frost7th Worcester1/31/2025Todd M. Smola1st Hampden3/10/2025Hannah Kane11th Worcester1/31/2025 1 of 2
HOUSE DOCKET, NO. 2249 FILED ON: 1/15/2025
HOUSE . . . . . . . . . . . . . . . No. 1205
By Representative Jones of North Reading, a petition (accompanied by bill, House, No. 1205) of
Bradley H. Jones, Jr. and others relative to establishing a commission (including members of the
General Court) to study the promotion of preferred pharmacy networks where insurers can
negotiate lower drug prices. Financial Services.
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 1053 OF 2023-2024.]
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Fourth General Court
(2025-2026)
_______________
An Act establishing a commission to study the promotion of preferred pharmacy networks.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 Notwithstanding any general or special law to the contrary, there shall be a commission
2to study the implementation of preferred pharmacy networks, whereby health insurers steer
3consumers to lower-cost “preferred” pharmacies where insurers can negotiate lower drug prices.
4 The commission shall consist of the house and senate chairs of the joint committee on
5health care financing, who shall serve as the co-chairs; one member to be appointed by the
6speaker of the house of representatives; one member to be appointed by the president of the
7senate; one member to be appointed by the house minority leader; one member to be appointed
8by the senate minority leader; the director of the health policy commission or a designee; the 2 of 2
9commissioner of the department of public health or a designee; and the executive director of the
10center for health information and analysis or a designee.
11 The commission shall study the feasibility of implementing preferred pharmacy networks
12and make recommendations based on a cost-benefit analysis of such networks. The commission
13shall provide estimates of projected savings in prescription drug costs from implementing such
14networks.
15 The commission shall submit its report and findings, along with any recommendations
16and drafted legislation, to the house and senate committees on ways and means, the joint
17committee on health care financing, and the clerks of the house of representatives and senate
18within 12 months of the passage of this act.